ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Faslodex, Injektionslösung - 2 Spritze(n)
56778012 AstraZeneca AG
Faslodex, Injektionslösung19.03.2004
Original19.03.2004
Fulvestrant (L02BA03) 
WHO-DDD 
07.16.20.2 Spritze(n)
07.16.20. 
B  
Yes 
IP 
329.81Yes
    
10 %379.80
7680567780121Synthetika
4826501 
Composition
fulvestrantum 250 mg, ethanolum 96 per centum 500 mg, alcohol benzylicus 500 mg, benzylis benzoas 750 mg, ricini oleum virginale q.s. ad solutionem pro 5 ml corresp., ethanolum 12 % V/V.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Fulvestrant250mg / 5ml
BAG: Active AgentDose
Fulvestrant250 mg
 
Inactive agentsDose
Alcohol Benzylicus500mg / 5ml
Benzyl Benzoate750mg / 5ml
Ethanolum 96 Per Centum500mg / 5ml
Ricini Oleum Virginale 
 
Source
Data was imported : 07.06.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home